-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Downgrades Afya to Neutral, Lowers Price Target to $16

Benzinga·01/16/2026 13:42:21
Listen to the news
UBS analyst Andre Salles downgrades Afya (NASDAQ:AFYA) from Buy to Neutral and lowers the price target from $18 to $16.